John Quisel, J.D., Ph.D.

John Quisel, J.D., Ph.D.

President and Chief Executive OfficeratDisc Medicine· In proxies 2022–2025

Pay in FY2025+10% from the year before · Disc Medicine stock +25.3% the same year

John Quisel, J.D., Ph.D. was paid $10.0M in FY2025 (Dec), up 10%. Disc Medicine stock rose 25.3% that year.

Pay$100 in the stock at the end of FY21 → $273
Pay is from the Summary Compensation Table of each Disc Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Disc MedicinePublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +203%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?